LOT Network "Patent Troll" Protection Examined

Published Jan 03, 2023 14:57 PM

“Patent trolls” have become such a problem for technology firms, including those in the physical security sector, that an organization has formed with the sole purposes of helping businesses thwart them.

IPVM Image

LOT Network is a nonprofit consortium that now boasts more than 2,600 members including Amazon, Google, IBM, Microsoft, and Tesla and represents more than 3.5 million patent assets. The group has not been shy about publicizing its rapid growth and has regularly issued media releases detailing its expanding membership base.

In this report, we examine LOT Network, how it works, who has joined, and what benefits it might be able to offer companies in the security sector.

Rise ** *** *******

*** *******, ***** ****** ** "******* ** Transfer," *** ******* ** **** ** Google, *****, *** ***, *** *** as * ********* **********. *** ***** *** ******, * ****** **** ********* ** intellectual ******** *** ******* ************* **** ARM *** ** **-***** ****** ********** patent ********* *** *********** ** *****, the ***** *** ***** ******* **** the **** ******* *****.

** ****** ****,**** ******** ************* ** *** ******* *** ************ as *** ***** ******. ** ******** 2022, *** *********** ** *** **** **** *,*** members********* *****-***** **** ********* *****, ******** and *-******** ******* *******.

IPVM Image

******* **** **** ** ***** ** countries, *** ******* * **** ***** of **** ******** *** ***** *********. They ********* ********** ********* *******, *******, automotive, *************, **********. *** ******* *** encompasses **** **** *.* ******* *******.

*** ******* "*** ******* ************ **** an ********** ** *** ****-**** ********, to *** ******* ****** ********* ** companies ******* *** *** *****,”****** **** ** ***** ****. *** ********** *** *** ***** to * ******* *** ******* **** IPVM.

Patent ******

******** ***** ** “****** ********* ********,” patent ****** *** ******** ******** ****** for *** **** ******* ** ********* patents *** ********* **** ******* ********* to ****** ********* ******* ** *********** litigation ** ** ******* ***** *********** and *********. *** *************** ** *** *******:

******** **** ****** ********* ******** (****, sometimes ****** '****** ******') *** ** a ***** ** ********* *** *** company. ****'* *** ******* ********* **** come ******** ** **** * *************, voluntary ********* ** ****** **** **** *** **** ***** ** ********** as *** ******** *********** ******* ************ uncertain.

*** ********** **** **** "*** ********** is **** ******** ** ****," ** a ****** ** ********* ******* ******* to ******** ******** ****** *** ***** Recession ** ****. ********* ** *** Network, **** ** ******* ** *** patent ***** ******* ****** ******.

IPVM Image

"Herd ************"

*** ********** ***** ** ****** ******* to **** ******** *********** ********** *** ** ***** ******* ***** prevents *** ******* ***** ** *** entity ** *** ***** **** **** being ******** ******* ******* ** ***** sold ** * ****** *****. *** conditional ******* **** ******* **** ****** Assertion ********, ** ******* ** *** agreement, ******** * ****** **** *** of *** ******* ** *** *****. (An ******* ******* ** *** ******* agreement, **** ****,** **** ********* ****.)

** * ******, ******* *** *** be ********* ******* *** ******** **** patent ********* ********, *** **** ** least ** *** **** ** **** with ******** **** ***** ******** **** any ******* ***** ***** ******* ***** when **** ****** *** ***** **** later **** ** ****** ******. *** Network ********* *** ******** ** "**** immunization."

"*** *** ****** *** ****** ** the *** ******* *** ********** **** patent," *** ********** **** ** *** website.*********, ******* *** ***** ********* ** use ***** ******* ** **** *** fit, ** ******* **** ** ********* them ** **********, ********* ** ****** ******** *** **********. ******* ** *** group *** ***** *** **** *****, or ****** ****, **** ******* ****** infringement ** **** ** **** ***'* fit *** ********** ** * ****** assertion ******.

********** **** *** "********* *** *********** **** ** *******, yet ****** * ******* *** **** those ****** ******* **** *** ***** of * ***,"****** ****.

*** ********* ******* ********** **** ******* from $*,*** ** $**,*** *** ****, depending ** *** ****'* *******. ***** with **** **** $** ******* ** annual ******* *** **** *** ****.

IPVM Image

Security ******** ***********

****** ********* ******** **** ******* ******** lawsuits ******* ********* ** *** ******** security ********** ******** **** *** **** year ** **. ********* ********* *********, Dahua, ********, *** ******* **** *** recently **** *** ****** ** ******** by ******** **** ******** ****** ** patents.

*** ********, *** ******, * ******** company **** * ****** ****** ********,***** *************** ******* ********* ** ********* **** including *******, ******, *****, *** **&* over ******* ************ ** * ***** detection-related ******.

** ******-***** ****** ******** ** ******* USA ************* ** ******* *********** ********* *** ***** **** ******* infringement ** ***** ******-******* *******. ******* patent ********** ******, *** ******, ***********-***** Network-1 ************ ***., ***** ** ******** traded,*** **** **** ************** ******* **** **** ******* ************ of * ****** ******** ** *** Power-over-Ethernet ********.

*****, *********, *******, *** ***** *** members, ****** *******'* ****** *********. ********* ***** ***. **, ****,***** ***** *** **, ****, ******* since ***. **, ****, *** ***** since **** **, ****.

*** ****** ** ******* ******* ****, Avigilon, *******, ******, *********, *****/*******, ***, Motorola, *** *********.

*******

***** *** *********** ***** ** ****** litigation *** *** ********** ****** ** lawsuits ** "****** ******," ******** ********** companies *** **** ***** ** *** type ** ********** ******* ** *** LOT *******.

*** ********** ** ****** *** ********* ** **** ******* **** * patent ***** ** *** ***** ** sold ** * ****** ***** — but ** *** ***** ** * prophylactic ******* ********* ********** ***** ** the ******. ******* **** ** ***** in *** *.*., *** ****** ** patents *** ***** *** *** ** much ** *** *****' ***** ** past ******* ***** ******* ******,********* ** *** ******** *** ***********.

Comments